Ask AI
ProCE Banner Activity

Early Clues, Lasting Impact: Detecting and Treating Alzheimer’s Disease in Its Earliest Stages 

Slideset

Download this slideset summarizing key updates presented at the 18th annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference. Expert-curated conference coverage includes new scientific data, supporting background context, and clinical commentary.

Released: January 20, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by an educational grant from Novo Nordisk.

Novo Nordisk

Target Audience

This activity is intended for neurologists, geriatricians, psychiatrists, primary care physicians, nurse practitioners, physician associates, and other healthcare professionals who manage patients with AD.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Implement evidence-based approaches to incorporate cognitive screening tools into routine practice for earlier identification of Alzheimer’s disease

  • Explain the underlying mechanisms of Alzheimer’s disease, including amyloid and tau pathology, neuroinflammation, and other emerging pathways

  • Evaluate the latest clinical efficacy and safety data for current and emerging treatments for AD

  • Apply current evidence supporting novel diagnostic strategies, including biomarkers, to identify early Alzheimer’s disease pathology in clinical practice